# US 2016/0354450 A1 · Method for Treating Adhesive Capsulitis

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2016/0354450 A1
- Document ID: US20160354450A1
- Status: Published application
- Kind: A1
- Application number: 15/173,497
- Filed: 2016-06-03
- Published: 2016-12-08
- Earliest claimed: 2005-01-21
- Assignees: The Research Foundation for The State University of New York
- Applicants: The Research Foundation for The State University of New York
- Inventors: Marie A. Badalamente; Edward Wang
- Web page: https://patentgrep.com/patent/US20160354450A1

## CPC

- A61K 38/4886: {Metalloendopeptidases (3.4.24), e.g. collagenase}
- A61P 19/02: for joint disorders, e.g. arthritis, arthrosis
- A61P 29/00: Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- C12Y 304/24007: Interstitial collagenase (3.4.24.7), i.e. matrix metalloprotease 1 or MMP1
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C12Y: ENZYMES

## Abstract

The invention relates to the discovery that collagenase injections are effective in lyse the collagenous adhesions in the shoulder and treat the disorder, adhesive capsulitis. As such, the invention relates to methods of treating or preventing adhesive capsulitis, or frozen shoulder, in a patient in need of such treatment comprising injecting or otherwise delivering an effective amount of collagenase to the collagenous adhesions in the shoulder. The invention also relates to the use of collagenase in the manufacture of a medicament to treat adhesive capsulitis.

## Claims

### Claim 1

A method of treating or preventing adhesive capsulitis in a subject in need of such treatment comprising delivering an effective amount of collagenase to collagenous adhesions in the shoulder.

### Claim 2 (depends on 1)

The method according to claim 1, wherein the collagenase is derived from Clostridium histolyticum.

### Claim 3 (depends on 2)

The method according to claim 2, wherein the collagenase is injected in a dose comprising at least about 700 SRC units.

### Claim 4 (depends on 3)

The method according to claim 3, wherein the collagenase is injected in a volume of less than 0.5 ml.

### Claim 5 (depends on 3)

The method according to claim 3, wherein the collagenase comprises collagenase I and collagenase II.

### Claim 6 (depends on 4)

The method according to claim 4, wherein the injection is delivered in a single injection between the interval of the deltoid and pectoral muscles.

### Claim 7 (depends on 1)

The method according to claim 1, wherein the subject is a human patient.

### Claim 8 (depends on 7)

The method according to claim 7, wherein the patient is characterized by an active forward elevation of only 90 degrees and an active external rotation of less than 50 degrees.

### Claim 9 (depends on 1)

The method according to claim 1, wherein after one month of receiving at least one administration of collagenase, the patient achieves an active external rotation of greater than 15 degrees, as compared to baseline.
